Detalhe da pesquisa
1.
Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection.
Bone Marrow Transplant
; 34(8): 683-91, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15322567